Digital CBT for Anxiety in Cardiovascular Disease Patients
Trial Summary
What is the purpose of this trial?
The treatment of generalized anxiety disorder (GAD) in an accessible manner represents an unmet need for those with cardiovascular disease (CVD), given that patients with CVD experience numerous barriers for in-person treatment engagement. The research plan for the proposed pilot project will entail: (1) open study of the acceptability of the digital intervention (N=5), followed by (2) recruitment and randomization of 90 individuals with a history of acute CVD events and clinical levels of GAD symptoms to dCBT or a waitlist (Control) condition, using a 1.5:1 allocation (dCBT:Control).
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, if you have started or changed the dosage of any psychotropic medications (medications that affect your mood, thoughts, or behavior) in the past 4 weeks, you may not be eligible to participate.
What data supports the effectiveness of the treatment Daylight dCBT Application for anxiety in cardiovascular disease patients?
Research shows that digital cognitive behavioral therapy (dCBT) can help reduce anxiety and worry in patients with cardiovascular disease, which may improve their overall heart health. Additionally, digital CBT has been effective in reducing symptoms of anxiety and depression in other health conditions, suggesting it could be beneficial for cardiovascular patients as well.12345
Is digital cognitive behavioral therapy (dCBT) safe for humans?
How is the Daylight dCBT Application treatment different from other treatments for anxiety in cardiovascular disease patients?
The Daylight dCBT Application is unique because it offers a digital, scalable, and affordable way to address anxiety in cardiovascular disease patients, who often face barriers to in-person therapy. Unlike traditional treatments, this digital cognitive behavioral therapy (dCBT) can be accessed remotely, making it more accessible and convenient for patients.12349
Eligibility Criteria
This trial is for adults over 18 who've had a recent acute cardiovascular event like a heart attack or stroke and are experiencing anxiety. They must be past the initial recovery phase, which means at least 2 months since their cardiac event, and have clinical levels of generalized anxiety.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Open Study
Open study of the acceptability of the digital intervention with a small group of participants
Treatment
Participants are randomized to receive digital CBT or placed on a waitlist control condition
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Daylight dCBT Application
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor